ALDH1A1 and triple-negative breast carcinoma: To characterize chemo-treated breast cancer patient-derived KU-CSLCs, a triple negative breast cancer cell line, MDA-MB231, and KU-CSLC cells, were analyzed for the expression of ALDH1, CXCR4, and CD133 while using RT-PCR.